In this paper I contend that criminological debate regarding the contribution of the fields of medicine, genetics and technology, in enhancing our understanding of the causes of crime, has been conceptually blinked by long-standing positional and ethical debates concerning the role of biological factors in criminal behaviour, with the result that we are guilty of failing to recognise that a fundamental shift is occurring within modern biomedicine from a ‘disease-therapy’ to ‘enhancement’ model of human health and well-being. Yet this development, I argue, possesses far reaching implications for criminology as a public-facing discipline concerned with promoting social justice and progressive social change. As a result, it is important to unpack the parameters of this biomedical shift, as well as situate it is not only in the context of emerging disciplinary subfields such as neurocriminology and behavioural economics (or nudging as it is sometimes referred to), but also challenge current biosocial and bioethical arguments for state-endorsed regimes of moral enhancement.
|Publication status||Published - 10 Apr 2017|
|Event||Critical Approaches to Risk and Security - Singapore Institute of Technology, Singapore, Singapore|
Duration: 10 Apr 2017 → 12 Apr 2017
|Conference||Critical Approaches to Risk and Security|
|Period||10/04/17 → 12/04/17|
Chamberlain, M. (2017). Crime, Biotechnologies and Risk: A Critical Appraisal. Paper presented at Critical Approaches to Risk and Security, Singapore, Singapore. https://singluv.com/singapore-institute-technology-critical-approaches-risk-security/